Educating Healthcare Professionals on AI in Alzheimer's Disease

Author:

Sharma Shweta1ORCID,Mansoori Shavez1,Goyal Manu1,Goyal Kanu1,Sharma Parul2

Affiliation:

1. Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar (Deemed), India

2. School of Physiotherapy, Delhi Pharmaceutical Sciences and Research University, India

Abstract

Alzheimer's disease (AD) is the main cause of dementia in older persons. Preclinical AD can persist anywhere from six to ten years, depending on when it first appears. Artificial intelligence (AI) is to create machines that are capable of doing tasks that would typically require human intelligence. Machine learning (ML), deep learning (DL), and natural language processing (NLP) are just a few of the approaches used in AI. Artificial intelligence tools are increasingly being used to predict the beginning or course of diseases, in addition to aiding in diagnosis. AI has shown to be a useful tool for improving customized care by providing the best possible treatment plans. AI can be used to diagnose diseases, provide customized treatment programs, and assist medical practitioners in making decisions. But in order to apply AI in healthcare ethically and successfully, problems with bias, security of data, and the need for human understanding must be addressed.

Publisher

IGI Global

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3